7.84
7.84 (0%)
As of Feb 14, 2025
Cryo Cell International Inc [CCEL]
Source:
Company Overview
Cryo-Cell International, Inc. is a Delaware corporation that was incorporated in 1989. The Company is organized in three reportable segments; 1.) cellular processing and cryogenic storage for family use, with a current focus on the collection and preservation of umbilical cord blood and tissue stem cells, 2.) the manufacture of PrepaCyte CB Processing System (“PrepaCyte CB”) units, the processing technology used to process umbilical cord blood stem cells, and 3.) cellular processing and cryogenic storage of umbilical cord blood stem cells for public use.
| Country | United States |
| Headquarters | oldsmar, florida |
| Phone Number | 813-749-2104 |
| Industry | services |
| CEO | David Portnoy And Mark Portnoy |
| Website | www.cryo-cell.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $32 |
| Operating Profit | $3.5 |
| Net Income | $0.4 |
| Net Cash | $0 |
Profit Ratios
| Gross Margin | $24 |
| Operating Margin | 10.9 |
| Profit as % of Revenues | 5,978.3% |
| Profit as % of Assets | 0.6% |
| Profit as % of Stockholder Equity | -3% |
Management Effectiveness
| Return on Equity | -3% |
| Return on Assets | 0.6% |
| Turnover Ratio | 50.8% |
| EBITA | $4 |
Balance Sheet and Cash Flow Measures
| Total Assets | $64.7 |
| Total Liabilities | $77.9 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0 |
